Subject Index For Volume 24  by unknown
Subject Index For Volume 24
Abdominal complications
in CAPD (abst) 412
Abdominal surgery
and chronic peritoneal dialysis (abst) 135
Acetate
and energy metabolism during hemodialysis S 16-97
high sodium bicarbonate dialysis compared to a. dialy-
sis 240
Acetohydroxamate
in struvite stones (abst) 425
Acetohydroxamic acid
treatment of ureogenic lithiasis (abst) 124
Acid-base status
after cannulation of aorta and vena cava 795
Acidosis
acquired distal renal tubular a.
Nephrology Forum on 807
chronic metabolic a.
effects on vitamin D metabolism in humans 644
Acidosis syndrome, acute
caused by acid pH of deionized water in hemodialysis
(abst) 269
Acids
metabolic generation of nonvolatile a 709
metabolism of orally administered branched-chain a-
ketoa S15-ll
Adenosine
intracortical distribution of RBF during infusion of
(abst) 272
Adrenal hormones
effects on epithelial function 386
Adriamycin
glomerular permeability and polyanion in A. nephrosis 152
Age
effects on endstage renal disease patient survival 691
impact of a. on effects of ureteral obstruction on renal
function 602
Albumin
isolation of inhibitors of ligand:a. binding from uremic
body fluids and normal urine S16-238
Aldosterone
and corticosterone effects on epithelial function 386
a. response to potassium loading in tubulointerstitial
renal disease 656
which type dopaminergic receptor modulates a. secre-
tion (abst) 826
1-Alea-hydroxycholecalciferol
treatment of secondary hyperparathyroidism of
chronic renal failure (abst) 128
Allergy
postvaccination lipoid nephrosis and a. to egg proteins
(abst) 821
Allograft, renal
and pretransplant antibodies (abst) 413
cytotoxic suppressor cells in r. a. rejection (abst) 414
effects of perioperative blood transfusions on r. a. sur-
vival (abst) 413
rejection of r. a. by urinary cytology (abst) 284
rupture in (abst) 268
Allotransplantation, renal
hepatitis B vaccination after (abst) 275
Aluminum
and renal osteodystrophy (abst) 820
effects on
calcium and PTH metabolism in hemodialysis and
CAPD (abst) 269
calcium and PTH response in CAPD (abst) 126
effective a. free intestinal phosphate binder in chronic
renal failure (abst) 417
history/incidence of a.-induced anemia, bone diseases,
and progressive encephalopathy (abst) 279
in joint tissues of chronic renal failure (abst) 405
in vivo a. absorption by duodenum in chronic uremia
(abst) S16-333
S. aluminum
in a. regular dialysis unit of North Greece
(abst) S16-333
Aluminum hydroxide
effects on hemoglobin and blood transfusions in hemo-
dialysis (abst) 416
risk of a. toxicity in a. h. therapy (abst) 126
treatment of severe renal failure and vitamin D disor-
ders Sl5-63
Aluminum toxicity
risk of a. t. in a. hydroxide therapy (abst) 126
American Rheumatism Association
criteria used in lupus and nonlupus membranous gb-
merulopathy study 377
Amino acids
acute uremia effects on protein degradation and a.
a. release in rat hemicorpus Sl6-43
and alpha analogues in three low-nitrogen diets for se-
verely uremic children S 16-290
and keto acid supplements
in children with chronic renal failure 95
to treat chronic uremia S16-285
as therapy in renal failure (abst) Sl6-328
branched-chain a. a. metabolism in chronic renal fail-
ure S16-17
effects of
a. a. infusions on cell metabolism in hemodialyzed
patients with uremia S16-87
renal substitute programs on a. a. patterns in chronic
uremia S16-77
in azotemia S 16-58
intracellular a. a. in uremia S 16-9
in uremia S 16-2
peritoneal ammonia as possible inhibitor for blood a. a.
loss S16-71
plasma ammonia effects on cellular release of
branched-chain a. a. in systemic portal encephalop-
athy S 16-67
potentiation of ischemic renal injury by a. a. infusion 620
relationship between branched-chain a. and a-keto a.
in blood in uremia S16-61
taurine metabolism in experimental renal failure ... S 15-16
use of keto analogues of essential a. a. in chronic renal
failure 515-11
Ammonia
colon a. reabsorption in uremia (abst) S16-338
peritoneal a.
as possible inhibitor for blood amino acid loss.... S16-7
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Ammonium chloride
used to induce metabolic acidosis 644
Amphiuma
chloride reabsorption in diluting segment of A. affected
by potassium (abst) 281
Androgens
as therapy in nonferropenic patients on hemodialysis
(abst) 269
Anaphylatoxin
a. formation during hemodialysis 764, 770
Anemia
in chronic endstage renal disease S16-218
induced by aluminum in home hemodialysis (abst) .... 279
pathogenesis of a. of uremia S 16-204
secondary hyperparathyroidism effects on a. of end-
stage renal failure (abst) 417
Anesthesia
open renal biopsy technique performed with local a. . 804
Angiotensin II
role in sodium excretion, urinary concentration, and
papillary plasma flow (abst) S 16-3 33
Angiotensin converting enzyme inhibitors influence on
hypercoagulability (abst) 283
Anionic ferritin
in glomerular permeability 632
Ankylosing spondylitis
and IgA nephropathy (abst) 408
associated with Berger disease (abst) 129
Anorexia
importance of a. in preservation of renal function due
to deficient phosphorus diets (abst) S 16-349
Antibodies
amonoclonal a.
used to define new pattern of passive Heymann ne-
phritis (abst) 824
antistreptococcal a.
and glomerulonephritis (abst) 821
B lymphocyte a. in controlled trial of cyclosporin A af-
ter renal transplantation (abst) 269
monoclonal a.
directed against human factor B (abst) 409
lymphocyte subsets in renal graft biopsy detected by
(abst) 414
production of m. a. against kidney cell populations
(abst) 407
used to detect organo-specific antigen on human kid-
ney structures (abst) 280
pretransplant a.
and renal allograft survival (abst) 413
role in IgA nephropathy and ankylosing spondylitis
(abst) 408
Antidiuretic hormone
interaction of cyclic AMP and calcium-calmodulin in
mechanism of (abst) 282
Antigens
iron overload related to HLA a. (abst) 412
organospecific a.
detected on human kidney structures by monoclonal
antibodies (abst) 280
Antiserum
in mouse with membranous glomerulonephritis 303
Aprotinin
effects on captropril associated with tubuloglomerular
feedback (abst) 282
Arachidonic acid metabolites
associated with macrophages (abst) 404
Arginine vasopressin
associated with BP in potassium deficiency 342
Ascites
cure for a. of dialyzed uremic patients (abst) S 16-346
Assay
fetal mouse liver cell used to measure serum erythro-
poietin in children with chronic renal failure S15-70
Autoantibody synthesis
regulation of anti-GBM a. s. (abst) 404
Autoimmune nephritis model
regulation of anti-GBM autoantibody synthesis in (abst) 404
Autoimmunity
in thyroiditis in primary renal glycosuria (abst) 825
Autoradiography
a. analysis of cell renewal of glomerular cell types in
normal rats 626
Azotemia
induced by diuretics (abst) Sl6-329
induced by diuretics Sl6-58
Bacterial infection
effect of uremia on resistance to 66
Bacterial lipopolysaccharide
used to study pathogenesis of increased glomerular per-
meability 632
Baroreflex
b. function affected by cold pressor test in essential hy-
pertension (abst) 127
Bartter syndrome
and polycythemia (abst) 822
Bayley-Pinneau method
used to predict adult height in children with chronic re-
nal failure S 15-48
Bence Jones proteinuria
in myeloma kidney cast nephropathy 192
Bence Jones tubulopathy
biochemical and morphological findings and therapeutic
results of B. J. t. (abst) 275
Berger disease, see IgA nephropathy
Berger glomerulonephritis
IgA1 and IgA2 subclasses in (abst) 128
factors of coagulation and fibrinolytic pathways in .... 137
Bicarbonate
high sodium b. dialysis compared to acetate dialysis .. 240
b. reabsorption
reduction of RBF and proximal b. r. in rats by genta-
micin 638
Biochemical assays
used to study recurrent calcium stone formers (abst) . 127
Biochemical data
selection, presentation, and interpretation of b. d. in
renal failure 438
Biopsy
muscle b. studies in chronic uremia S16-334
Biopsy, renal
lymphocyte subsets detected by monoclonal antibodies
in (abst) 414
modified open kidney b. technique 804
post-r. b. follow-up in patients with IgA mesangial de-
posit glomerulonephritis (abst) 825
role in
management of idiopathic nephrotic syndrome,
Nephrology Forum on 561
renal transplantation 210
used to study focal glomeruloscierosis and proteinuria
after nephrectomy 649
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Biopterin metabolism
in chronic uremia (abst) 138
Bleeding
Nephrology Forum on uremic b 698
Blood
gastrointestinal b. loss in patients on maintenance dial-
ysis S16-218
b. interactions of dialy sate and membranes (abst) .... 404
relationship between branched-chain amino and a-keto
acids in b. in uremia S 16-61
BP
affected by arginine vasopressin in potassium deficien-
cy 342
as criterion used to select children in risk for essential
hypertension (abst) 826
associated with prostaglandin biosynthesis (abst) 283
dopaminergic control
in hemodialysis (abst) 412
of prolactin, sympathetic tone, and BP in hemodialy-
sis (abst) 828
Blood transfusions
effects of perioperative b. t. on renal allograft survival
(abst) 413
Bone resorption
stimulated by elevated serum 1 ,25-(OH)2-vitamin D
concentrations 555
Bone scintigraphy
role in diagnosis of renal osteodystrophy (abst) 126
Bovine serum albumin
used to induce chronic serum sickness in rats 160
Bowman's capsule
rate of cell renewal in B. c. cells 626
Brain
associated with branched-chain amino acid metabolism
in chronic renal failure S16-17
role in glucose production related to chronic renal fail-
ure S16-115
Brush border
new pattern of passive Heymann nephritis defined by
amonoclonal antibody directed against (abst) 824
Brushborder membrane, luminal
renal adaptation to altered dietary sulfur amino acid in-
take at 588
Calcium
affected by
aluminum in hemodialysis and CAPD (abst) 269
cimetidine in primary hyperparathyroidism (abst) ... 821
verapamil in essential hypertension (abst) 280
and magnesium tubular handling in stone formers (abst) 132
and PTH response affected by aluminum in CAPD
(abst) 126
C. excretion
in idiopathic hypercalciuria 549
in experimental uremia S 15-53
recurrent c. stone formers observed with biochemical
assays and crystalluria study (abst) 127
c, resorption stimulated by 1 ,25-(OH)2-vitamin D 555
role of intracellular c. and calmodulin in cellular metab-
olism Sl6-l61
Calcium-ATPase
endstage renal disease effects on responsiveness to cal-
modulin and thyroid hormone of c. in
erythrocytes S16-l67
Calcium-calmodulin
interaction with cyclic AMP in mechanism of antidi-
uretic hormone (abst) 282
Calcium oxalate crystallization
inhibitors of c. o, c. in urine from stone formers and
normal subjects (abst) 424
Calcium-phosphorus
c.-p. balance
associated with primary hyperparathyroidism (abst) 274
c. -p. metabolism
affected by CAPD (abst) 270
Calcium stone disease
idiopathic c. s. d.
critical evaluation of forms of therapy for (abst) .... 420
Calcium stone formers
inhibitor and nucleator activities in (abst) 424
Calmodulin
endstage renal disease effects on responsiveness to c.
and thyroid hormone of calcium-ATPase in erythro-
cytes Sl6-167
role of intracellular calcium and c. in cellular metabo-
lism S16-l61
Caloric supplementation
effects on growth in uremic children 205
Cancer
metastatic breast c.
9 hydroxy 2 methylellipticinum effects on (abst) .... 406
Cannulation
acid-base status after 795
Captopril
effects on sodium balance 233
fails to inhibit tubuloglomerular feedback responses
with aprotinin (abst) 282
graft function loss with transplant renal artery stenosis
after c. treatment (abst) 414
in sodiumlwater management in cirrhosis (abst) 271
recovery in postischemic acute renal failure with. S 16-324
severe side effects of c. in advanced chronic kidney in-
sufficiency (abst) 423
Carbohydrate metabolism
during fasting in chronic hemodialysis patients 222
studied by hyperglycemia clamp technique in children
with chronic renal failure S 15-22
Carcinogenesis
precarcinogen nitrosodimethylamine in small intestine
in chronic renal failure S16-229
Cardiac arrhythmia
in chronic dialysis patients (abst) 821
Cardiac function
affected by acetate and bicarbonate hemodialysis 782
in children with chronic renal failure Sl5-77
in experimental uremia Si 5-83
Cardiovascular changes
in chronic hemodialysis 371
Cardiovascular diseases
open heart surgery in endstage renal disease (abst).... 413
Carnitine
loss of c. in hemodialysis and hemofiltration Si6-143
plasma and muscle levels of c. in hemodiaiysis (abst). 125
L-Carnitine
as treatment in hemodiaiysis (abst) Si6-332
effects in anemia of hemodialysis patients (abst) .. S 16-332
metabolic effects on regular dialysis treatment
(abst) S 16-327
nutritional response patterns to L-c. in patients on
chronic hemodialysis (abst) S 16-328
Catabolism
exercise training effects on muscle protein c. in
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uremia S16-52
role of increased peripheral c. unmasked through evis-
ceration hepatectomy S16-58
Catecholamines
myocardial response to c. in experimental uremia.. S15-83
Catheter, Hickman
Technical Note on 694
Cefoperazone
in CAPD (abst) 404
Cells
arterial smooth muscle c. proliferation in renovascular
hypertension (abst) 127
cytotoxic suppressor c. in renal allograft rejection
(abst) 414
double-diffusion c. used to study middle molecules... 250
endothelial c. death linked to systemic familial hyalino-
sis (abst) 406
isolated from limb of Henle (abst) 406
c. metabolism
effects of amino acid infusions on c. m. in uremia S 16-87
role of intracellular calcium and calniodulin in c. m. S16-161
c. renewal of glomerular cell types in normal rats 626
suppressor C.
characteristics of s. c. in pyelonephritis 313
in mercuric chloride-induced autoimmune nephritis
(abst) 406
Cell-mediated immunity
cells identified in nonspecific suppression of 313
Cellulose phosphate test
used to determine type of hypercalciuria (abst) 283
Cerebro-spinal fluid
sodium in (abst) 273
Chemotactic activity
generated by dialyzer membrane 775
Chloride
in cells of ioop of Henle (abst) 277
c. reabsorption in diluting segment of Amphiuma
affected by potassium (abst) 281
Chiorothiazide
in familial hypocalciuric hypercalcemia 353
Chromatography
anion exchange c. used to study middle molecules .... 250
Cimetidine
in primary hyperparathyroidism (abst) 821
Cirrhosis
alcoholic liver c.
immune complexes containing IgA1 and IgA2 in
(abst) 825
mechanisms of improvement of water and sodium
excretion by immersion in 788
captopril effects on sodium/water management in (abst) 271
insertion of peritoneoveinous shunt in c. patients (abst) 821
membranoproliferative glomerulonephritis in (abst).... 131
sodium tubular handling in (abst) 271
Cis-platin nephrotoxicity
enzymuria in evaluation of (abst) 125
Cis-platinum
effects on human kidney proximal tubule (abst) 131
Cloning techniques
in monoclonal antibodies to human renal basement
membranes 74
Coagulation disorders
in nephrotic syndrome (abst) 822
Coagulation, intravascular
renal tubular obstruction during 323
Cold pressor test
effects on baroreflex function in essential hypertension
(abst) 127
Collagen, type IV
in biopsy specimens of renal interstitial fibrosis (abst) 824
Complement system
affected by monoclonal antibodies (abst) 409
associated with leukopenia in hemodialysis 775
inherited c. component deficiencies in membranoprolif-
erative glomerulonephritis 681
symptoms and activation of granulocytes and c. with
two dialysis membranes 758
Computer model system
used to make physico-chemical studies of urine (abst) 134
Computerized medical record
in nephrology 446
Computer systems
BASIC S16-343
CLINFO 464
CSA 496
CUSUMS 474
DEC 455
ICD-9 464
RSX-11M 455
SPSS 464
TMR 446
Computing in clinical nephrology, Symposium on bio-
chemical data in renal failure in 438
computer methods, uremic encephalopathy, and ade-
quacy of dialysis 496
computerized clinical data for dialysis and transplanta-
tion units in 455
computerized medical record in 446
computerized medical record for patients with endstage
renal disease 464
graft survival after renal transplantation analyzed 516
introductions to Symposium on 433, 436
kinetic modeling applied to renal and related diseases 487
mathematical/statistical aids to evaluate data from renal
patients in 474
use of European Registries in treatment of endstage re-
nal disease 507
Congestive cardiomyopathy
with moderate renal failure treated with CAPD (abst). 136
Corticosteroid therapy
in acute renal failure (abst) 404
ocular changes in idiopathic nephrotic syndrome after
(abst) 271
used in Henoch-Schönlein glomerulonephritis (abst)... 409
Corticosterone
and aldosterone effects on epithelial function 386
Cuprophan
eosinophilia and pulmonary dysfunction in c. hemodial-
ysis 246
Cyclic AMP
and PTH in idiopathic hypercalciuria S16-l75
interaction with calcium-calmodulin in mechanism of
antidiuretic hormone (abst) 282
urinary
as index of parathyroid function in hypercalciuria
(abst) 134
u. c. excretion in primary hyperparathyroidism and
recurrent calcium nephrolithiasis (abst) 138
Cyclophosphamide
effects on peripheral T cell subsets in polyarteritis no-
dosa (abst) 273
used in Henoch-Schänlein glomerulonephritis (abst) .. 409
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Cyclosporin A
as treatment in
kidney transplants (abst) 280
segmental neoprene-injected pancreas transplantation
(abst) 428
cortical infarction in rabbits with serum sickness after
(abst) 416
in controlled trial after renal transplantation (abst) .... 269
Cystinosis
multicenter study of 105 patients in Federal Republic of
Germany (abst) 277
Cystinuria
treated with alpha-mercaptopropionylglycine (Thiola®)
(abst) 420
Cytomegalovirus infection
diagnosed by urinary cytology in renal transplantation
(abst) 284
Deferoxamine
used to remove iron during CAPD 110
DOCA-salt
used to induce hypertension 731
Diabetes
diagnosis of protein calorie malnutrition in d. patients
on hemodialysis and peritoneal dialysis (abst)... S16-342
40-month study of CAPD in insulin-dependent d. pa-
tients (abst) 136
hemofiltration treatment in diabetic uremic patients
(abst) 135
reduced intracellular pyruvate availability in S 16-6 1
Diabetes mellitus
disorder of magnesium renal tubular transport in (abst) 272
Dialysate
uremic neuropathy and hypogeusia improved by d. zinc
supplementation Sl6-315
who needs high sodium d.? (abst) 827
Dialysis (also see Hemodialysis)
associated with humoral immunodepression (abst) .... 413
chronic d.
cardiac arrhythmia in (abst) 821
compared to transplantation in study of effects of age
on endstage renal disease patient survival 691
computer methods, uremic encephalopathy, and ade-
quacy of 496
computerized clinical data for 455
d. fluid
influence on membrane biocompatibility (abst) 270
gastrointestinal blood loss in patients undergoing main-
tenance d S 16-218
hemodialysis
acetate and energy metabolism during S 16-97
acute acidosis syndrome in (abst) 269
aluminum hydroxide effects on (abst) 416
aluminum treatment in (abst) 405
and hemofiltration in systemic portal
encephalopathy S 16-67
and indomethacin used to treat uremic pericarditis . 663
androgen therapy in nonferropenic patients on (abst) 269
carnitine loss during h. and hemofiltration S 16-143
clinical features of non-A, non-B hepatitis in patients
and staff of h. center (abst) 137
chronic h.
carbohydrate metabolism during fasting in 222
cardiovascular changes in 371
hepatitis B vaccination protocols in uremic pa-
tients treated with (abst) 138
high sodium bicarbonate and acetate h 240
malnutrition as factor in morbidity and mortality of
h. patients S 16-199
comparison of cellophane and cellulose acetate mem-
branes in 758
comparison of new and re-used dialyzer membranes
in 770
different dialyzer membranes used to study leukope-
nia and complement system in 775
effects of
acetate and bicarbonate h. on cardiac function.... 782
aluminum on calcium and PTH metabolism in h.
and CAPD (abst) 269
amino acid infusions on cell metabolism in h. pa-
tients with uremia 5 16-87
different dialyzer membranes in 764
enhanced release of granulocyte proteinases in ure-
mic intoxication and during S 16-27
eosinophilia and pulmonary dysfunction in cupro-
phan h 246
exercise training for h. patients S 16-303
Hickman catheter used as new h. access device for
infants and small children 694
in lupus nephritis (abst) 416
in polycystic kidney disease (abst) 406
kinetic modeling of h., hemofiltration, and hemodia-
filtration 143
leukocyte metabolism studied in h. patients Sl6-93
muscle biopsy studies done on chronic uremic pa-
tients on S16-187
new thrombin inhibitor (MD-805) suitable for (abst) 412
non-A-non-B hepatitis in (abst) 272, 416
PTH response to hypocalcemia in 364
protein and energy requirements in children on .. S 15-6
protein malnutrition in (abst) 405
results of short-term h. (abst) 412
simulation study on transcellular fluid shifts induced
by 542
triiodothyronine and thyroxine in chronic renal fail-
ure patients on S16-180
vasoactive hormones in children with chronic renal
failure on S 15-27
hepatitis HbS vaccination in (abst) 413
peritoneal
and indomethacin used to treat uremic pericarditis . 663
peritonitis treated in (abst) 130
chronic p.
and abdominal surgery in 25 patients (abst) 135
continuous ambulatory p. d. (CAPD)
abdominal echography and long-term peritoneum
efficiency in (abst) 133
and renal transplantation (abst) 406
calcium and PTH response affected by aluminum
in CAPD (abst) 126
carbohydrate metabolism in (abst) S 16-329
Cefoperazone in (abst) 404
correlation between peritonitis and nutritional state
in patients on CAPD (abst) S16-34l
effects of aluminum on calcium and PTH metabo-
lism in h. and CAPD (abst) 269
effects of different concentrations of calcium and
magnesium in solutions for (abst) S16-334
effects on calcium-phosphorus metabolism and
PTH (abst) 270
effects on circadian behavior of cortisol and aldos-
terone (abst) Sl6-337
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erythrocytic metabolism and oxidative hemolysis
during (abst) S 16-341
erythropoietin and uremic toxicity during .... 516-208
40-month study in insulin-dependent diabetic pa-
tients (abst) 136
improved lymphocyte transformation in patients
on CAPD (abst) 411
iron removal during CAPD using deferoxamine ... 110
long-term survival on (abst) 428
multicenter study of physical activity and employ-
ment status of United States patients on (abst). 412
muscle biopsy studies done on chronic uremia pa-
tients on S16-187
1981 report of 450 patients of 21 sample centers in
Italy (abst) 136
nutritional/metabolic studies in children on ... S15-106
nutritional requirements for patients on 5 16-295
oral supplementation of essential amino acids in
(abst) S16-349
plasma concentrations and transperitoneal trans-
port of native insulin and C-peptide in patients
on (abst) 421
severe abdominal complications in (abst) 412
small solutes kinetics in CAPD (abst) 270
treatment of congestive cardiomyopathy with mod-
erate renal failure (abst) 136
20-month experience of CAPD in pediatric
patients S15-lOl
"Y" connector system to prevent peritonitis in
(abst) 411
modeling in 487
p. transport in rabbits related to p. d. in children
with chronic renal failure S 15-89
report on regular d. and transplantation in Europe
XIII, 1982, Parts I, II, and III (abst) 411
sodium-dependent transcellular water shift during
(abst) 820
total parenteral nutrition for acute renal failure patients
on S16-319
Dialysis water
as cause of bone intoxication by aluminum (abst) 820
Dialyzer membranes
comparison of
cellophane and cellulose acetate membranes in he-
modialysis 758
new and re-used d. m 770
effects of different d. membranes in hemodialysis 764
hemodialysis leukopenia and complemented function
with different d. m 775
Diet
effects on plasma acid-base composition in normal hu-
mans 670
role of d. factors in chronic renal disease 579
Dietary protein
and urea kinetics in hemofiltration (abst)
Dilatation, percutaneous transluminal
used in renovascular hypertension (abst)
Diphenylthiazole
used to induce renal cystic disease
Donnan effect
related to sieving coefficient (abst) 133
Dopamine
controls
prolactin, sympathetic tone, and BP in hemodialysis
patients (abst)
sympathetic activity and BP in hemodialysis (abst) . 412
d. receptors
role in regulation of renin-angiotensin-aldosterone
system (abst) 826
Dyslipidemia
and nutritional factors in hemodialysis patients
(abst) Sl6-332
post-transplant d.
diet therapy for (abst) S16-331
Echocardiogram
assessed cardiac function in children with chronic renal
failure S15-77
Echography, abdominal
used to investigate abdominal cavity (abst) 133
Eclampsia
hemodynamic effect of magnesium sulfate in (abst).... 822
Egg proteins
postvaccination lipoid nephrosis and allergy to (abst) . 821
Electrocautery
high current e. used in open kidney biopsy technique. 804
Electroencephalogram
used in acute renal failure 170
Electrolytes
muscle intracellular e. in uremic patients S16-l53
renal e. gradient evaluated by in situ tissue impedance
studies 800
Encephalopathy
progressive e.
induced by aluminum in home hemodialysis (abst) . 279
systemic portal e.
plasma ammonia effects on cellular release of
branched-chain amino acids in S16-67
Endocrine system
nutritional and e. status in patients on regular hemodi-
alysis treatment (abst) Sl6-334
e. response of peritoneal and enteral administered glu-
cose to patients on CAPD (abst) 5 16-337
Energy
and acetate metabolism during hemodialysis 5 16-97
Enzymuria
and proteinuria in hypertension (abst) 130
used to study
cis-platin effects on human kidney proximal tubule
(abst) 131
cis-platin nephrotoxicity (abst) 125
Eosinophilia
during cuprophan hemodialysis 246
Epinephrine
effects on potassium metabolism (abst) 272
Epithelial function
adrenal hormone effects on 386
Erythrocytes
135 endstage renal disease effects on responsiveness to cal-
modulin and thyroid hormone of calcium-ATPase in
human e S 16-167
279 Erythropoiesis
feedback regulation of e. in kidney transplant patients
with polycythemia 227
Erythropoietin
and uremic toxicity during CAPD S 16-208
Ethylene glycol
nephron damage due to e. g. poisoning (abst) 415
Escherichia co/i
828 experimental infections of bacteremia and peritonitis . 66
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European Dialysis and Transplant Association
computerized methodologies used in 507
European Registries
evolving methodologies in computerized E. R 507
Eurotransplant
computerized methodologies used in 507
Exercise
benefits for hemodialysis patients S 16-303
e. training effects on muscle protein catabolism in ure-
mia S16-52
Extracellular fluid volume
affected by potassium in hypertension 731
Fabry disease
associated with rapidly progressive glomerulonephritis
with granulomatous hyperplasia of gums (abst) 130
discovered by isolated nephrologic symptoms (abst) .. 405
Factor VIII
in severe essential arterial hypertension (abst) 273
Fasting
carbohydrate metabolism during f. in chronic hemodial-
ysis patients 222
Fc receptor blockade
during Plasmodium yoeli infection (abst) 132
Feedback regulation
of erythropoiesis in renal transplant patients with poly-
cythemia 227
Fibrin
affected by renal tubular obstruction 323
Fibronectin
in biopsy specimens of renal interstitial fibrosis (abst) 824
significance off. in human glomerulonephritis (abst)... 827
Fibrosis
renal interstitial f.
immunocytochemical and ultrastructural study of
(abst) 824
Fluid
simulation study on transcellularj. shifts induced by
hemodialysis 542
f. transport
paracellular shunt ultrastructure and changes in f. t. in
Necturus proximal tubule 610
Flumequine
ocular changes during treatment of (abst) 405
Furosemide
and captopril effects on BP 233
effects on ouabain-resistant rate constant of sodium ef-
flux in hypertension (abst) 826
in familial hypocalciuric hypercalcemia 353
renal volume response to f. in renovascular hyperten-
sion (abst) 825
response of kidney to 233
Gastrointestinal system
blood loss in g. s. of patients on maintenance
dialysis S16-218
Gentamicin
cortical and papillary absorptive defects in g. nephro-
toxicity 526
effects on tubular obstruction in acute renal failure.... 330
reduction of RBF and proximal bicarbonate reabsorp-
tion in rats by 638
Glomerular basement membrane
influence of GBM width on glomerular capillary wall
(abst) 280
proteoglycans in (abst) 279
Glomerular blood flow
and filtration in different nephron populations after
ischemia (abst) 280
Glomerular capillary wall
influenced by width of glomerular basement membrane
(abst) 280
Glomerular diseases
plasma exchange in (abst) 133
damaged by p-aminophenol 740
Glomerular hematuria
urine sediment in (abst) 135
Glomerular infiltration
during Plasmodium yoeli infection (abst) 132
Glomerular permeability
altered g. p. in early phase of immune complex nephri-
tis 632
and polyanion in Adriamycin nephrosis 152
Glomerular polyanion
affected by vasoactive factor in normal rat serum
(abst) 410
and permeability in Adriamycin nephrosis 152
Glomerulonephritis
antistreptococcal antibodies and (abst) 821
associated with scleritis (abst) 405
chronic g.
decreased capacity of serum to solubilize circulating
immune complexes in patients with (abst) 826
de novo membranous g.
following renal transplantation (abst) 414
developed from toxic oil syndrome (abst) 273
human g.
significance of fibronectin in (abst) 827
immune-complex g.
following allogenic kidney transplantation
(abst) 283
IgA membranoproliferative g.
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